Piper Sandler Starts Immunovant (IMVT) at Overweight
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $43.71 +4.52%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Immunovant (NASDAQ: IMVT) with a Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.47 yesterday.
You May Also Be Interested In
- BMO Capital Starts Cadillac Mines Corp (CADY:CN) at Outperform
- Jefferies Assumes Honeywell International (HON) at Hold
- Citi Starts Banco Mercantil do Brasil (BMEB4:BZ) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
